查看购物车
  • Traditional Chinese
  • English
  • Japanese
  • Korean
全球影像服务市场：按模式(MRI,超声,CT,X光,核成像,乳房X光检查),应用(妇产科,骨盆/腹部,心臟病学,肿瘤学,神经病学),技术,用户(医院,诊断中心)到2027全球预测
市场调查报告书
商品编码
1132171

全球影像服务市场：按模式(MRI,超声,CT,X光,核成像,乳房X光检查),应用(妇产科,骨盆/腹部,心臟病学,肿瘤学,神经病学),技术,用户(医院,诊断中心)到2027全球预测

Diagnostic Imaging Services Market by Modality (MRI, Ultrasound, CT, X-RAY, Nuclear Imaging, Mammography), Application (OB/Gyn, Pelvic/Abdomen, Cardiology, Oncology, Neurology), Technology, User (Hospitals, Diagnostic Centers) - Global Forecast to 2027
出版日期: | 出版商: MarketsandMarkets | 英文 225 Pages | 订单完成后即时交付

价格
简介目录

到 2027 年，全球诊断影像服务市场预计将达到 7026 亿美元，高于 2022 年的 5490 亿美元，预测期内的复合年增长率为 5.1%。

市场增长的主要驱动力包括全球各种慢性病发病率的上升、对各种成像方式的认识提高以及动态成像中心的扩张。

然而，诊断成像设备的高成本、低经济地区采用新诊断成像技术的缓慢以及熟练人力资源的短缺预计将限制市场的增长。

“X 射线在 2021 年占全球诊断影像服务市场的最大份额”

根据模式，市场分为 X 射线、计算机断层扫描、超声波、MRI、核成像和乳房 X 光检查。 2021 年，X 射线细分市场在诊断影像服务市场中占据最大份额。这是由于世界各地的医院和诊断中心越来越多地使用数字 X 射线成像方式。 X 射线扫描的技术进步，例如 HiP-CT(分层相位对比断层扫描)，它以十倍于 CT 扫描仪的分辨率提供全身 3D 图像，也有望支持该领域的发展。不久的将来。我来了。

“2021 年，神经科在 MRI 成像服务市场中占据最大份额”

根据应用，MRI 服务市场分为神经科、骨科、心血管科、盆腔/腹部和肿瘤科。神经病学领域将在 2021 年占据 MRI 服务市场的最大份额。这是由于人口日益老龄化、神经退行性疾□□病和创伤性脑损伤的发病率增加、MRI 成像技术的进步以及越来越多的公司采用新的 MRI 技术来预测各种神经系统疾病。

“预计亚太地区在预测期内的复合年增长率最高”

诊断影像服务市场分为四个主要区域：北美、欧洲、亚太地区、拉丁美洲以及中东和非洲。 2021年，北美占全球诊断影像服务市场的最大份额。然而，亚太地区将在预测期内实现最高增长率，这主要是由于改善了医疗基础设施、增加了对诊断成像的投资、改善了报销方案、增加了医疗旅游以及扩大了几个亚太地区国家的保险覆盖范围。预计将以 6.1%d 的复合年增长率增长。此外，预计亚洲国家新诊断中心和医院的建立将在预测期内推动亚太地区的市场增长。

内容

第一章介绍

第二章研究方法

第 3 章执行摘要

第 4 章重要注意事项

第 5 章市场概述

  • 简介
  • 市场动态
    • 驱动程序
    • 约束因素
    • 机会
    • 任务
  • 价格分析
  • 生态系统分析：诊断影像服务市场
  • 监管分析
  • 兑换场景
  • 价值链分析
  • 波特五力分析
  • 专利分析
  • 重大会议和活动(2022-2023)
  • 影响客户业务的趋势/中断
  • 主要利益相关者和采购标准
  • 最终用户的主要购买标准

第 6 章诊断成像服务市场：按模式分类

  • 简介
  • 磁共振成像 (MRI)
  • 超声波
  • 计算机断层扫描 (CT)
  • X 射线
  • 核成像 (SPECT/PET)
  • 乳房 X 光检查

第 7 章诊断成像服务市场：按应用分类

  • 简介
  • 磁共振成像 (MRI)
    • 神经
    • 骨科
    • 心脏病学
    • 骨盆/腹部
    • 肿瘤
    • 其他
  • 超声波
    • 妇产科
    • 心血管
    • 泌尿科
    • 神经
    • 骨科
    • 其他
  • 计算机断层扫描 (CT)
    • 心脏病学
    • 肿瘤
    • 神经
    • 其他
  • X 射线
    • 普通射线照相
    • 牙科
    • 其他
  • 核成像服务
    • 神经
    • 肿瘤
    • 心脏病学
    • 其他
  • 乳房 X 光检查

第 8 章诊断成像服务市场：按技术分类

  • 简介
  • 二维成像技术
  • 3D/4D 成像技术

第 9 章诊断成像服务市场：按最终用户分类

  • 简介
  • 医院
  • 影像诊断中心
  • 门诊中心
  • 研究和学术

第 10 章诊断成像服务市场：按地区划分

  • 简介
  • 北美
    • 美国
    • 加拿大
  • 欧洲
    • 德国
    • 英国
    • 法国
    • 意大利
    • 西班牙
    • 其他
  • 亚太地区
    • 中国
    • 日本
    • 印度
    • 韩国
    • 澳大利亚
    • 其他
  • 拉丁美洲
  • 中东和非洲

第 11 章竞争格局

  • 概览
  • 大公司/龙头公司的招聘策略
  • 利润分析
  • 诊断成像服务市场：市场份额分析，按主要参与者(2021 年)
  • 主要公司的企业评价象限(截至 2021 年)
  • 企业评估象限(中小企业/初创企业)
  • 竞争基准
  • 竞争情景(2019-2022 年)

第 12 章公司简介

  • RADNET, INC.
  • SONIC HEALTHCARE
  • AKUMIN INC.
  • HEALIUS LIMITED
  • DIGNITY HEALTH
  • NOVANT HEALTH
  • ALLIANCE MEDICAL
  • INHEALTH GROUP
  • APEX RADIOLOGY
  • CONCORD MEDICAL SERVICES HOLDINGS LIMITED
  • RAYUS RADIOLOGY(CENTER FOR DIAGNOSTIC IMAGING, INC.)
  • UNILABS
  • AFFIDEA
  • I-MED RADIOLOGY NETWORK
  • CAPITOL IMAGING SERVICES
  • SIMONMED
  • CANADA DIAGNOSTIC CENTRES(CDC)
  • SHIELDS HEALTH CARE GROUP
  • ENVISION RADIOLOGY
  • PROGRESSIVE RADIOLOGY
  • 其他公司
    • QSCAN SERVICES PTY LTD
    • PRP DIAGNOSTIC IMAGING
    • INOVA
    • ATLANTIC MEDICAL IMAGING
    • ADVANCED DIAGNOSTICS HEALTHCARE SYSTEM, INC.

第十三章附录

简介目录
Product Code: MD 7453

The diagnostic imaging services market is projected to reach USD 702.6 billion by 2027 from USD 549.0 billion in 2022, at a CAGR of 5.1% during the forecast period. Major factors driving the growth of market includes rising global incidence of various chronic diseases, growing awareness about the different imaging modalities, and growing expansion of outpatient imaging centers

However, high cost associated with diagnostic imaging equipment; reducing the adoption of new imaging technology among lower economic countries and shortage of skilled workforce is anticipated to restrain the growth of market.

"X-ray accounted for the largest share of the global diagnostic imaging services market in 2021".

Based on Modality, the market is segmented into X-ray , computed tomography, ultrasound, MRI, nuclear imaging, and mammography. In 2021, the x-ray segment accounted for the largest share of the diagnostic imaging services market. This is attributed to the increased usage of digital X-ray imaging modality among hospitals & diagnostic centers across the globe. Additionally, ongoing technological upgradation in X-ray scan such as Hierarchical Phase-Contrast Tomography (HiP-CT) , offering 3D image of whole body scan with the resolution 10 times greater than CT scanner , are anticipated to support the growth of the segment in the near future.

"The neurology segment accounted for the largest share of the MRI imaging services market in 2021".

Based on application, the MRI services market is segmented into neurology, orthopedics, cardiovascular, pelvic & abdomen, and oncology. The neurology segment accounted for the largest share of the MRI services market in 2021. This is attributed to the increased aged population and growing incidences of neurodegenerative disorders, traumatic brain injuries, advancements in MRI imaging technology and growing number of players introducing new MRI technology for prediction of various neurological disorders.

The Asia Pacific market is estimated to grow at the highest CAGR during the forecast period.

The diagnostic imaging services market is segmented into four major regions, namely, North America, Europe, the Asia Pacific, Latin America and Middle East & Africa. In 2021, North America commanded the largest share of the global diagnostic imaging service market. However, the Asia Pacific market is estimated to grow at the highest CAGR of 6.1%during the forecast period primarily due to the improving healthcare infrastructure, rising investments in diagnostic imaging, improving reimbursement scenario, rising medical tourism, and the growing insurance coverage in several APAC countries. Furthermore, establishment of new diagnostic centers and hospitals in Asian Countries are expected to propel the growth of market in the Asia Pacific during the forecast period.

Breakdown of supply-side primary interviews:

  • By Company Type: Tier 1 - 48%, Tier 2 - 36%, and Tier 3 - 16%
  • By Designation: C-level - 10%, Director-level - 14%, and Others - 76%
  • By Region: North America- 40%, Europe - 32%, APAC - 20%, and RoW - 8%

The major player in the market includes RadNet, Inc. (US), Sonic Healthcare (Australia), Akumin Inc. (US), Healius Limited (Australia), RAYUS Radiology (US), Dignity Health (US), Novant Health (US), Alliance Medical (UK), InHealth Group (UK), Apex Radiology (Australia), Concord Medical Services Holdings Limited (China), Unilabs (Switzerland), Affidea (Netherlands), I-MED Radiology Network (Australia), Capitol Imaging Services (US), SimonMed (US), among others.

Research Coverage

This research report categorizes the diagnostic imaging services market, by modality, application, technology, end user, and region. The report also studies factors (such as drivers, restraints, opportunities, and challenges) affecting market growth and provides details of the competitive landscape for market leaders. Furthermore, the report analyzes micromarkets with respect to their individual growth trends and forecasts the revenue of the market segments with respect to five major regions (and the respective countries in these regions).

Key Benefits of Buying the Report

This report focuses on various levels of analysis-industry trends, market share of top players, and company profiles, which together form basic views and analyze the competitive landscape, emerging segments of the global diagnostic imaging services market, and high-growth regions and their drivers, restraints, opportunities, and challenges. The report will help both established firms as well as new entrants/smaller firms to gauge the pulse of the market and garner greater market shares.

TABLE OF CONTENTS

1 INTRODUCTION

  • 1.1 STUDY OBJECTIVES
  • 1.2 MARKET DEFINITION
  • 1.3 MARKET SCOPE
    • 1.3.1 MARKETS COVERED
    • 1.3.2 GEOGRAPHIC SCOPE
    • 1.3.3 INCLUSIONS & EXCLUSIONS
    • 1.3.4 YEARS CONSIDERED
  • 1.4 CURRENCY CONSIDERED
  • 1.5 LIMITATIONS
  • 1.6 MARKET STAKEHOLDERS
  • 1.7 SUMMARY OF CHANGES

2 RESEARCH METHODOLOGY

  • 2.1 RESEARCH METHODOLOGY
    • FIGURE 1 RESEARCH DESIGN
    • 2.1.1 SECONDARY RESEARCH
    • 2.1.2 PRIMARY RESEARCH
      • 2.1.2.1 Key data from primary sources
    • FIGURE 2 BREAKDOWN OF PRIMARY INTERVIEWS: SUPPLY-SIDE AND DEMAND-SIDE PARTICIPANTS
    • FIGURE 3 BREAKDOWN OF SUPPLY-SIDE PRIMARY INTERVIEWS: BY COMPANY TYPE, DESIGNATION, AND REGION
  • 2.2 MARKET SIZE ESTIMATION
    • FIGURE 4 RESEARCH METHODOLOGY: HYPOTHESIS BUILDING
    • 2.2.1 REVENUE MAPPING-BASED MARKET ESTIMATION
    • 2.2.2 DIAGNOSTIC IMAGING SERVICES CONSUMPTION-BASED MARKET ESTIMATION
    • FIGURE 5 MARKET SIZE ESTIMATION: OVERALL DIAGNOSTIC IMAGING SERVICES MARKET
    • 2.2.3 PRIMARY RESEARCH VALIDATION
  • 2.3 DATA TRIANGULATION
    • FIGURE 6 DIAGNOSTIC IMAGING SERVICES MARKET: DATA TRIANGULATION METHODOLOGY
  • 2.4 RESEARCH ASSUMPTIONS AND LIMITATIONS
    • 2.4.1 RESEARCH ASSUMPTIONS
    • 2.4.2 RESEARCH LIMITATIONS

3 EXECUTIVE SUMMARY

    • FIGURE 7 DIAGNOSTIC IMAGING SERVICES MARKET, BY MODALITY, 2022 VS. 2027 (USD BILLION)
    • FIGURE 8 X-RAY IMAGING MARKET, BY APPLICATION, 2022 VS. 2027 (USD BILLION)
    • FIGURE 9 DIAGNOSTIC IMAGING SERVICES MARKET, BY TECHNOLOGY, 2022 VS. 2027 (USD BILLION)
    • FIGURE 10 DIAGNOSTIC IMAGING SERVICES MARKET, BY END USER, 2022 VS. 2027 (USD MILLION)
    • FIGURE 11 GEOGRAPHICAL SNAPSHOT OF DIAGNOSTIC IMAGING SERVICES MARKET

4 PREMIUM INSIGHTS

  • 4.1 DIAGNOSTIC IMAGING SERVICES MARKET OVERVIEW
    • FIGURE 12 EARLY DISEASE DETECTION AND RISING INCIDENCE OF AGE-ASSOCIATED DISEASES TO DRIVE MARKET
  • 4.2 DIAGNOSTIC IMAGING SERVICES MARKET FOR COMPUTED TOMOGRAPHY (CT) APPLICATION, 2022 VS. 2027 (USD BILLION)
    • FIGURE 13 CARDIOVASCULAR SEGMENT TO DOMINATE CT MARKET IN 2022
  • 4.3 EUROPE: DIAGNOSTIC IMAGING SERVICES MARKET, BY END USER AND COUNTRY
    • FIGURE 14 HOSPITALS SEGMENT IN EUROPE ACCOUNTED FOR LARGEST SHARE IN 2021
  • 4.4 GEOGRAPHIC SNAPSHOT OF DIAGNOSTIC IMAGING SERVICES MARKET
    • FIGURE 15 CHINA TO REGISTER HIGHEST CAGR DURING FORECAST PERIOD

5 MARKET OVERVIEW

  • 5.1 INTRODUCTION
  • 5.2 MARKET DYNAMICS
    • FIGURE 16 DIAGNOSTIC IMAGING SERVICES MARKET: DRIVERS, RESTRAINTS, OPPORTUNITIES, AND CHALLENGES
    • 5.2.1 DRIVERS
      • 5.2.1.1 Rising geriatric population and subsequent increase in age-related diseases
    • TABLE 1 AGE-RELATED DISEASES AND OTHER ASSOCIATED DIAGNOSTIC MODALITIES
      • 5.2.1.2 Growing awareness of early disease detection and broad scope of clinical applications
    • TABLE 2 EMERGING APPLICATIONS OF DIAGNOSTIC IMAGING
      • 5.2.1.3 Technological advancements in diagnostic imaging
      • 5.2.1.4 Growing preference for outpatient imaging centers
    • TABLE 3 HOSPITAL PRICES AS A PERCENTAGE OF OUTPATIENT IMAGING PRICES
    • 5.2.2 RESTRAINTS
      • 5.2.2.1 High cost of diagnostic imaging systems
      • 5.2.2.2 Low reimbursement for outpatient imaging facilities
    • TABLE 4 MEDICARE REIMBURSEMENT TRENDS BY IMAGING MODALITY (2007-2019)
    • 5.2.3 OPPORTUNITIES
      • 5.2.3.1 Adoption of AI and blockchain
      • 5.2.3.2 High growth opportunities in emerging countries
    • 5.2.4 CHALLENGES
      • 5.2.4.1 Shortage of skilled radiologists
      • 5.2.4.2 Hospital budget cuts
  • 5.3 PRICING ANALYSIS
    • 5.3.1 AVERAGE SELLING PRICE OF DIAGNOSTIC IMAGING SERVICES BY KEY PLAYERS
    • TABLE 5 MODALITY - MRI SCAN
    • TABLE 6 MODALITY - CT SAN
    • TABLE 7 MODALITY - X-RAY
    • TABLE 8 MODALITY - PET SCAN
    • TABLE 9 AVERAGE SELLING PRICE OF DIAGNOSTIC IMAGING MODALITY TREND (USD)
  • 5.4 ECOSYSTEM ANALYSIS: DIAGNOSTIC IMAGING SERVICES MARKET
  • 5.5 REGULATORY ANALYSIS
    • TABLE 10 KEY REGULATORY BODIES & GOVERNMENT AGENCIES
    • 5.5.1 KEY REGULATORY GUIDELINES
      • 5.5.1.1 US
    • TABLE 11 US FDA: MEDICAL DEVICE CLASSIFICATION
    • TABLE 12 US: MEDICAL DEVICE REGULATORY APPROVAL PROCESS
      • 5.5.1.2 Canada
    • TABLE 13 CANADA: MEDICAL DEVICE REGULATORY APPROVAL PROCESS
      • 5.5.1.3 Europe
      • 5.5.1.4 Japan
    • TABLE 14 JAPAN: MEDICAL DEVICE CLASSIFICATION UNDER PMDA
      • 5.5.1.5 China
    • TABLE 15 CHINA: CLASSIFICATION OF MEDICAL DEVICES
      • 5.5.1.6 India
  • 5.6 REIMBURSEMENT SCENARIO
    • TABLE 16 MEDICAL REIMBURSEMENT CPT CODES FOR MRI PROCEDURES (AS OF 2022) (US)
    • TABLE 17 MEDICAL REIMBURSEMENT CPT CODES FOR CT IMAGING PROCEDURES (AS OF 2022) (US)
    • TABLE 18 MEDICAL REIMBURSEMENT CODES FOR PET/CT IMAGING PROCEDURES (AS OF 2022) (US)
    • TABLE 19 MEDICAL REIMBURSEMENT CODES FOR ULTRASOUND IMAGING PROCEDURES (AS OF 2021) (US)
    • TABLE 20 MEDICAL REIMBURSEMENT CODES FOR MAMMOGRAPHY IMAGING PROCEDURES (AS OF 2021) (US)
    • TABLE 21 MEDICAL REIMBURSEMENT CODES FOR X-RAY IMAGING PROCEDURES (AS OF 2021) (US)
    • 5.6.1 COMMERCIAL REIMBURSEMENT: DIAGNOSTIC IMAGING SERVICES
  • 5.7 VALUE CHAIN ANALYSIS
    • 5.7.1 RESEARCH & DEVELOPMENT
    • 5.7.2 MANUFACTURING & ASSEMBLY
    • 5.7.3 DISTRIBUTION, MARKETING & SALES, AND POST-SALES SERVICES
    • FIGURE 17 VALUE CHAIN ANALYSIS
  • 5.8 PORTER'S FIVE FORCES ANALYSIS
    • 5.8.1 OVERVIEW
    • TABLE 22 DIAGNOSTIC IMAGING SERVICE MARKET: PORTER'S FIVE FORCES ANALYSIS
    • 5.8.2 BARGAINING POWER OF BUYERS
    • 5.8.3 BARGAINING POWER OF SUPPLIERS
    • 5.8.4 THREAT OF NEW ENTRANTS
    • 5.8.5 THREAT OF SUBSTITUTES
    • 5.8.6 INTENSITY OF COMPETITIVE RIVALRY
  • 5.9 PATENT ANALYSIS
    • FIGURE 18 MAJOR PATENT HOLDERS FOR ULTRASOUND IMAGING SYSTEMS (JANUARY 2011 TO AUGUST 2022)
    • FIGURE 19 MAJOR PATENT HOLDERS FOR MAGNETIC RESONANCE IMAGING SYSTEMS (JANUARY 2011 TO AUGUST 2022)
    • FIGURE 20 MAJOR PATENT HOLDERS FOR CT IMAGING SYSTEMS (JANUARY 2011 TO AUGUST 2022)
    • FIGURE 21 MAJOR PATENT HOLDERS FOR MAMMOGRAPHY SYSTEMS (JANUARY 2011 TO AUGUST 2022)
    • FIGURE 22 MAJOR PATENT HOLDERS FOR NUCLEAR IMAGING SYSTEMS (JANUARY 2011 TO AUGUST 2022)
    • FIGURE 23 MAJOR PATENT HOLDERS FOR X-RAY SYSTEMS (JANUARY 2011 TO AUGUST 2022)
    • FIGURE 24 JURISDICTION ANALYSIS: TOP APPLICANT COUNTRIES FOR DIAGNOSTIC IMAGING PATENTS, 2011-2022
  • 5.10 KEY CONFERENCES & EVENTS (2022-2023)
    • TABLE 23 DIAGNOSTIC IMAGING SERVICES MARKET: DETAILED LIST OF MAJOR CONFERENCES & EVENTS
  • 5.11 TRENDS/DISRUPTIONS IMPACTING CUSTOMERS' BUSINESSES
    • FIGURE 25 EMERGING TRENDS AND OPPORTUNITIES AFFECTING FUTURE REVENUE MIX
  • 5.12 KEY STAKEHOLDERS & BUYING CRITERIA
    • 5.12.1 KEY STAKEHOLDERS
    • FIGURE 26 INFLUENCE OF STAKEHOLDERS IN BUYING PROCESSES FOR DIFFERENT IMAGING MODALITIES/PROCEDURES
    • TABLE 24 INFLUENCE OF STAKEHOLDERS PURCHASING SERVICES FOR TOP 3 IMAGING MODALITIES/PROCEDURES (%)
  • 5.13 KEY BUYING CRITERIA, BY END USER
    • TABLE 25 KEY BUYING CRITERIA FOR BUYING MODALITY SEGMENTS

6 DIAGNOSTIC IMAGING SERVICES MARKET, BY MODALITY

  • 6.1 INTRODUCTION
    • TABLE 26 DIAGNOSTIC IMAGING SERVICES MARKET, BY REGION, 2020-2027 (USD BILLION)
    • TABLE 27 DIAGNOSTIC IMAGING SERVICES MARKET, BY MODALITY, 2020-2027 (USD BILLION)
  • 6.2 MAGNETIC RESONANCE IMAGING (MRI)
    • 6.2.1 ACCURATE DISEASE STAGING AND EFFECTIVE RESPONSE IN TREATMENT OF CHRONIC CONDITIONS TO DRIVE MARKET
    • TABLE 28 MAGNETIC RESONANCE IMAGING SERVICES MARKET, BY REGION, 2020-2027 (USD BILLION)
    • TABLE 29 MAGNETIC RESONANCE IMAGING SERVICES MARKET, BY END USER, 2020-2027 (USD BILLION)
  • 6.3 ULTRASOUND
    • 6.3.1 RISING DEVELOPMENT OF POC ULTRASOUND SYSTEMS TO SUPPORT MARKET GROWTH
    • TABLE 30 ULTRASOUND SERVICES MARKET, BY REGION, 2020-2027 (USD BILLION)
    • TABLE 31 ULTRASOUND SERVICES MARKET, BY END USER, 2020-2027 (USD BILLION)
  • 6.4 COMPUTED TOMOGRAPHY (CT)
    • 6.4.1 RISING ADOPTION OF CT SCANNERS FOR DETECTION OF TUMORS TO SUPPORT MARKET GROWTH
    • TABLE 32 COMPUTED TOMOGRAPHY SERVICES MARKET, BY REGION, 2020-2027 (USD BILLION)
    • TABLE 33 COMPUTED TOMOGRAPHY SERVICES MARKET, BY END USER, 2020-2027 (USD BILLION)
  • 6.5 X-RAY
    • 6.5.1 LOWER COST OF X-RAY IMAGING COMPARED TO OTHER MODALITIES TO DRIVE MARKET
    • TABLE 34 X-RAY SERVICES MARKET, BY REGION, 2020-2027 (USD BILLION)
    • TABLE 35 X-RAY SERVICES MARKET, BY END USER, 2020-2027 (USD BILLION)
  • 6.6 NUCLEAR IMAGING (SPECT/PET)
    • 6.6.1 STRINGENT REGULATIONS AND UNCERTAIN REIMBURSEMENT SCENARIOS TO RESTRAIN MARKET
    • TABLE 36 NUCLEAR IMAGING SERVICES MARKET, BY REGION, 2020-2027 (USD BILLION)
    • TABLE 37 NUCLEAR IMAGING SERVICES MARKET, BY END USER, 2020-2027 (USD BILLION)
  • 6.7 MAMMOGRAPHY
    • 6.7.1 RISING BREAST CANCER CASES TO DRIVE DEMAND FOR 3D MAMMOGRAMS
    • TABLE 38 MAMMOGRAPHY SERVICES MARKET, BY REGION, 2020-2027 (USD BILLION)
    • TABLE 39 MAMMOGRAPHY SERVICES MARKET, BY END USER, 2020-2027 (USD BILLION)

7 DIAGNOSTIC IMAGING SERVICES MARKET, BY APPLICATION

  • 7.1 INTRODUCTION
    • TABLE 40 DIAGNOSTIC IMAGING SERVICES MARKET, BY APPLICATION, 2020-2027 (USD BILLION)
  • 7.2 MAGNETIC RESONANCE IMAGING (MRI)
    • TABLE 41 DIAGNOSTIC IMAGING SERVICES MARKET FOR MAGNETIC RESONANCE IMAGING, BY APPLICATION, 2020-2027 (USD BILLION)
    • 7.2.1 NEUROLOGY
      • 7.2.1.1 Innovations in 3D MRI technology to have wide applications in neurology
    • 7.2.2 ORTHOPEDICS
      • 7.2.2.1 MRI procedures to be effective in diagnosis & prognosis of musculoskeletal disorders
    • TABLE 42 MAGNETIC RESONANCE IMAGING SERVICES MARKET FOR ORTHOPEDIC APPLICATIONS, BY REGION, 2020-2027 (USD BILLION)
    • 7.2.3 CARDIOVASCULAR
      • 7.2.3.1 MRI helps obtain high-resolution images of vascular systems
    • TABLE 43 MAGNETIC RESONANCE IMAGING SERVICES MARKET FOR CARDIOVASCULAR APPLICATIONS, BY REGION, 2020-2027 (USD BILLION)
    • 7.2.4 PELVIC & ABDOMEN
      • 7.2.4.1 Rising cases of kidney stones among individuals to support market growth
    • TABLE 44 MAGNETIC RESONANCE IMAGING SERVICES MARKET FOR PELVIC & ABDOMEN APPLICATIONS, BY REGION, 2020-2027 (USD BILLION)
    • 7.2.5 ONCOLOGY
      • 7.2.5.1 Rising prevalence of cancer and increasing awareness of early cancer screening to drive market
    • 7.2.6 OTHER MRI APPLICATIONS
  • 7.3 ULTRASOUND
    • TABLE 45 DIAGNOSTIC IMAGING SERVICES MARKET FOR ULTRASOUND, BY APPLICATION, 2020-2027 (USD BILLION)
    • 7.3.1 OBSTETRICS & GYNECOLOGY
      • 7.3.1.1 Rising number of maternity centers and diagnostic clinics to support market
    • TABLE 46 ULTRASOUND IMAGING SERVICES MARKET FOR OBSTETRICS & GYNECOLOGY APPLICATIONS, BY REGION, 2020-2027 (USD BILLION)
    • 7.3.2 CARDIOVASCULAR
      • 7.3.2.1 Increasing lifestyle changes and age-related disorders to drive market
    • TABLE 47 ULTRASOUND IMAGING SERVICES MARKET FOR CARDIOVASCULAR APPLICATIONS, BY REGION, 2020-2027 (USD BILLION)
    • 7.3.3 UROLOGY
      • 7.3.3.1 Growing incidence of urological disorders to support market growth
    • TABLE 48 ULTRASOUND IMAGING SERVICES MARKET FOR UROLOGY APPLICATIONS, BY REGION, 2020-2027 (USD BILLION)
    • 7.3.4 NEUROLOGY
      • 7.3.4.1 Increasing incidence of neuromuscular disorders to drive market
    • TABLE 49 ULTRASOUND IMAGING SERVICES MARKET FOR NEUROLOGY APPLICATIONS, BY REGION, 2020-2027 (USD BILLION)
    • 7.3.5 ORTHOPEDICS
      • 7.3.5.1 Increasing use of ultrasound in orthopedics due to absence of harmful ionization radiation
    • TABLE 50 ULTRASOUND IMAGING SERVICES MARKET FOR ORTHOPEDICS APPLICATIONS, BY REGION, 2020-2027 (USD BILLION)
    • 7.3.6 OTHER ULTRASOUND APPLICATIONS
    • TABLE 51 ULTRASOUND IMAGING SERVICES MARKET FOR OTHER ULTRASOUND APPLICATIONS, BY REGION, 2020-2027 (USD BILLION)
  • 7.4 COMPUTED TOMOGRAPHY (CT)
    • TABLE 52 DIAGNOSTIC IMAGING SERVICES MARKET FOR COMPUTED TOMOGRAPHY (CT), BY APPLICATIONS, 2020-2027 (USD BILLION)
    • 7.4.1 CARDIOVASCULAR
      • 7.4.1.1 Growing availability of cardiac CT devices in imaging to propel market
    • TABLE 53 COMPUTED TOMOGRAPHY MARKET FOR CARDIOVASCULAR APPLICATIONS, BY REGION, 2020-2027 (USD BILLION)
    • 7.4.2 ONCOLOGY
      • 7.4.2.1 Increasing incidence of cancer to drive market
    • TABLE 54 COMPUTED TOMOGRAPHY (CT) IMAGING SERVICES MARKET FOR ONCOLOGY APPLICATIONS, BY REGION 2020-2027 (USD BILLION)
    • 7.4.3 NEUROLOGY
      • 7.4.3.1 High prevalence of target diseases to support market growth
    • TABLE 55 COMPUTED TOMOGRAPHY (CT) IMAGING SERVICES MARKET FOR NEUROLOGY APPLICATIONS, BY REGION 2020-2027 (USD BILLION)
    • 7.4.4 OTHER COMPUTED TOMOGRAPHY (CT) APPLICATIONS
    • TABLE 56 COMPUTED TOMOGRAPHY (CT) IMAGING SERVICES MARKET FOR OTHER CT APPLICATIONS, BY REGION 2020-2027 (USD BILLION)
  • 7.5 X-RAY
    • TABLE 57 DIAGNOSTIC IMAGING SERVICES MARKET FOR X-RAY APPLICATIONS, 2020-2027 (USD BILLION)
    • 7.5.1 GENERAL RADIOGRAPHY
      • 7.5.1.1 Rising prevalence of lung diseases to drive market
    • TABLE 58 X-RAY IMAGING SERVICES MARKET FOR GENERAL RADIOLOGY APPLICATIONS, BY REGION, 2020-2027 (USD BILLION)
    • 7.5.2 DENTISTRY
      • 7.5.2.1 High prevalence of dental disorders to support dental screening
    • TABLE 59 X-RAY IMAGING SERVICES MARKET FOR DENTISTRY APPLICATIONS, BY REGION, 2020-2027 (USD BILLION)
    • 7.5.3 OTHER X-RAY APPLICATIONS
    • TABLE 60 DIAGNOSTIC IMAGING SERVICES MARKET FOR OTHER X-RAY APPLICATIONS, BY REGION, 2020-2027 (USD BILLION)
  • 7.6 NUCLEAR IMAGING SERVICES
    • TABLE 61 DIAGNOSTIC IMAGING SERVICES MARKET FOR NUCLEAR IMAGING, BY APPLICATIONS, 2020-2027 (USD BILLION)
    • 7.6.1 NEUROLOGY
      • 7.6.1.1 PET system to provide structural and functional information on brain functions
    • TABLE 62 NUCLEAR IMAGING SERVICES MARKET FOR NEUROLOGY APPLICATIONS, BY REGION, 2020-2027 (USD BILLION)
    • 7.6.2 ONCOLOGY
      • 7.6.2.1 Nuclear imaging systems distinguish benign and malignant tumors
    • TABLE 63 NUCLEAR IMAGING SERVICES MARKET FOR ONCOLOGY APPLICATIONS, BY REGION, 2020-2027 (USD BILLION)
    • 7.6.3 CARDIOVASCULAR
      • 7.6.3.1 High prevalence of CVD to drive market
    • TABLE 64 NUCLEAR IMAGING SERVICES MARKET FOR CARDIOVASCULAR APPLICATIONS, BY REGION, 2020-2027 (USD BILLION)
    • 7.6.4 OTHER NUCLEAR IMAGING APPLICATIONS
    • TABLE 65 NUCLEAR IMAGING SERVICES MARKET FOR OTHER NUCLEAR IMAGING APPLICATIONS, BY REGION, 2020-2027 (USD BILLION)
  • 7.7 MAMMOGRAPHY
    • 7.7.1 RISING CASES OF BREAST CANCER WORLDWIDE TO DRIVE MARKET
    • TABLE 66 DIAGNOSTIC IMAGING SERVICES FOR MAMMOGRAPHY APPLICATIONS, BY REGION, 2020-2027 (USD BILLION)

8 DIAGNOSTIC IMAGING SERVICES MARKET, BY TECHNOLOGY

  • 8.1 INTRODUCTION
    • TABLE 67 DIAGNOSTIC IMAGING SERVICES MARKET, BY TECHNOLOGY, 2020-2027 (USD BILLION)
  • 8.2 2D IMAGING TECHNOLOGY
    • 8.2.1 WIDE USAGE OF 2D IMAGING TECHNOLOGY ACROSS HEALTHCARE FACILITIES TO SUPPORT MARKET GROWTH
    • TABLE 68 DIAGNOSTIC IMAGING SERVICES MARKET FOR 2D IMAGING TECHNOLOGY, BY REGION, 2020-2027 (USD BILLION)
  • 8.3 3D/4D IMAGING TECHNOLOGY
    • 8.3.1 INCREASING NUMBER OF COMPANIES DEVELOPING 3D IMAGING EQUIPMENT TO DRIVE MARKET
    • TABLE 69 DIAGNOSTIC IMAGING SERVICES MARKET FOR 3D/4D IMAGING TECHNOLOGY, BY REGION, 2020-2027 (USD BILLION)

9 DIAGNOSTIC IMAGING SERVICES MARKET, BY END USER

  • 9.1 INTRODUCTION
    • TABLE 70 DIAGNOSTIC IMAGING SERVICES MARKET, BY END USER, 2020-2027 (USD BILLION)
  • 9.2 HOSPITALS
    • 9.2.1 RISING NUMBER OF DIAGNOSTIC IMAGING PROCEDURES PERFORMED IN HOSPITALS TO DRIVE MARKET
    • TABLE 71 DIAGNOSTIC IMAGING SERVICES MARKET FOR HOSPITALS, BY REGION, 2020-2027 (USD BILLION)
  • 9.3 DIAGNOSTIC IMAGING CENTERS
    • 9.3.1 GROWING ESTABLISHMENT OF PRIVATE IMAGING CENTERS TO DRIVE MARKET
    • TABLE 72 DIAGNOSTIC IMAGING SERVICES MARKET FOR DIAGNOSTIC IMAGING CENTERS, BY REGION, 2020-2027 (USD BILLION)
  • 9.4 AMBULATORY CARE CENTERS
    • 9.4.1 GROWING NUMBER OF ACCS TO SUPPORT MARKET GROWTH
    • TABLE 73 DIAGNOSTIC IMAGING SERVICES MARKET FOR AMBULATORY CARE CENTERS, BY REGION, 2020-2027 (USD BILLION)
  • 9.5 RESEARCH & ACADEMIA
    • 9.5.1 INCREASING RESEARCH ACTIVITIES IN CLINICAL APPLICATIONS TO SUPPORT MARKET GROWTH
    • TABLE 74 DIAGNOSTIC IMAGING SERVICES MARKET FOR RESEARCH & ACADEMIA, BY REGION, 2020-2027 (USD BILLION)

10 DIAGNOSTIC IMAGING SERVICES MARKET, BY REGION

  • 10.1 INTRODUCTION
    • TABLE 75 DIAGNOSTIC IMAGING SERVICES MARKET, BY REGION, 2020-2027 (USD BILLION)
  • 10.2 NORTH AMERICA
    • FIGURE 27 NORTH AMERICA: DIAGNOSTIC IMAGING SERVICES MARKET SNAPSHOT
    • TABLE 76 NORTH AMERICA: DIAGNOSTIC IMAGING MARKET, BY COUNTRY, 2020-2027 (USD BILLION)
    • TABLE 77 NORTH AMERICA: DIAGNOSTIC IMAGING SERVICES MARKET, BY MODALITY, 2020-2027 (USD BILLION)
    • TABLE 78 NORTH AMERICA: DIAGNOSTIC IMAGING SERVICES MARKET, BY END USER, 2020-2027 (USD BILLION)
    • TABLE 79 NORTH AMERICA: DIAGNOSTIC IMAGING SERVICES MARKET FOR X-RAY APPLICATIONS, 2020-2027 (USD BILLION)
    • TABLE 80 NORTH AMERICA: DIAGNOSTIC IMAGING SERVICES MARKET FOR MAGNETIC RESONANCE IMAGING (MRI) APPLICATIONS, 2020-2027 (USD BILLION)
    • TABLE 81 NORTH AMERICA: DIAGNOSTIC IMAGING SERVICES MARKET FOR COMPUTED TOMOGRAPHY (CT) APPLICATIONS, 2020-2027 (USD BILLION)
    • TABLE 82 NORTH AMERICA: DIAGNOSTIC IMAGING SERVICES MARKET FOR ULTRASOUND APPLICATIONS, 2020-2027 (USD BILLION)
    • TABLE 83 NORTH AMERICA: DIAGNOSTIC IMAGING SERVICES MARKET FOR NUCLEAR IMAGING APPLICATIONS, 2020-2027 (USD BILLION)
    • TABLE 84 NORTH AMERICA: DIAGNOSTIC IMAGING SERVICES MARKET, BY END USER, 2020-2027 (USD BILLION)
    • 10.2.1 US
      • 10.2.1.1 Increasing volume of diagnostic imaging procedures to drive market
    • TABLE 85 US: KEY GROWTH MACROINDICATORS
    • TABLE 86 US: DIAGNOSTIC IMAGING SERVICES MARKET, BY MODALITY, 2020-2027 (USD BILLION)
    • 10.2.2 CANADA
      • 10.2.2.1 Rising collaborations and investments by diagnostic imaging companies to support market growth
    • TABLE 87 CANADA: MAJOR INDICATORS OF MARKET GROWTH
    • TABLE 88 CANADA: DIAGNOSTIC IMAGING SERVICES MARKET, BY MODALITY, 2020-2027 (USD BILLION)
  • 10.3 EUROPE
    • FIGURE 28 EUROPE: CANCER PREVALENCE, BY COUNTRY, 2012-2030
    • TABLE 89 EUROPE: DIAGNOSTIC IMAGING SERVICES MARKET, BY COUNTRY, 2020-2027 (USD BILLION)
    • TABLE 90 EUROPE: DIAGNOSTIC IMAGING SERVICES MARKET, BY MODALITY, 2020-2027 (USD BILLION)
    • TABLE 91 EUROPE: DIAGNOSTIC IMAGING SERVICES MARKET FOR X-RAY APPLICATIONS, 2020-2027 (USD BILLION)
    • TABLE 92 EUROPE: DIAGNOSTIC IMAGING SERVICES MARKET FOR MAGNETIC RESONANCE IMAGING (MRI) APPLICATIONS, 2020-2027 (USD BILLION)
    • TABLE 93 EUROPE: DIAGNOSTIC IMAGING SERVICES MARKET FOR COMPUTED TOMOGRAPHY (CT) APPLICATIONS, 2020-2027 (USD BILLION)
    • TABLE 94 EUROPE: DIAGNOSTIC IMAGING SERVICES MARKET FOR ULTRASOUND APPLICATIONS, 2020-2027 (USD BILLION)
    • TABLE 95 EUROPE: DIAGNOSTIC IMAGING SERVICES MARKET FOR NUCLEAR IMAGING APPLICATIONS, 2020-2027 (USD BILLION)
    • TABLE 96 EUROPE: DIAGNOSTIC IMAGING SERVICES MARKET, BY END USER, 2020-2027 (USD BILLION)
    • 10.3.1 GERMANY
      • 10.3.1.1 Rising volume of imaging procedures to drive market
    • TABLE 97 GERMANY: DIAGNOSTIC IMAGING SERVICES MARKET, BY MODALITY, 2020-2027 (USD BILLION)
    • 10.3.2 UK
      • 10.3.2.1 Government initiatives to promote diagnostic imaging services to drive market
    • TABLE 98 UK: DIAGNOSTIC IMAGING SERVICES MARKET, BY MODALITY, 2020-2027 (USD BILLION)
    • 10.3.3 FRANCE
      • 10.3.3.1 High incidence of Alzheimer's and other neurological conditions to drive demand for MRI scans
    • TABLE 99 FRANCE: DIAGNOSTIC IMAGING SERVICES MARKET, BY MODALITY, 2020-2027 (USD BILLION)
    • 10.3.4 ITALY
      • 10.3.4.1 Rising senior population coupled with an established healthcare system to support market growth
    • TABLE 100 ITALY: DIAGNOSTIC IMAGING SERVICES MARKET, BY MODALITY, 2020-2027 (USD BILLION)
    • 10.3.5 SPAIN
      • 10.3.5.1 Rising expansion of diagnostic imaging service providers to drive market demand
    • TABLE 101 SPAIN: DIAGNOSTIC IMAGING SERVICES MARKET, BY MODALITY, 2020-2027 (USD BILLION)
    • 10.3.6 REST OF EUROPE (ROE)
    • TABLE 102 REST OF EUROPE: DIAGNOSTIC IMAGING SERVICES MARKET, BY MODALITY, 2020-2027 (USD BILLION)
  • 10.4 ASIA PACIFIC
    • FIGURE 29 ASIA PACIFIC: CANCER PREVALENCE, 2012-2030
    • FIGURE 30 ASIA PACIFIC: DIAGNOSTIC IMAGING SERVICES MARKET SNAPSHOT
    • TABLE 103 ASIA PACIFIC: DIAGNOSTIC IMAGING SERVICES MARKET, BY COUNTRY, 2020-2027 (USD BILLION)
    • TABLE 104 ASIA PACIFIC: DIAGNOSTIC IMAGING SERVICES MARKET, BY MODALITY, 2020-2027 (USD BILLION)
    • TABLE 105 ASIA PACIFIC: DIAGNOSTIC IMAGING SERVICES MARKET FOR X-RAY APPLICATIONS, 2020-2027 (USD BILLION)
    • TABLE 106 ASIA PACIFIC: DIAGNOSTIC IMAGING SERVICES MARKET FOR MAGNETIC RESONANCE IMAGING (MRI) APPLICATIONS, 2020-2027 (USD BILLION)
    • TABLE 107 ASIA PACIFIC: DIAGNOSTIC IMAGING SERVICES MARKET FOR COMPUTED TOMOGRAPHY (CT) APPLICATIONS, 2020-2027 (USD BILLION)
    • TABLE 108 ASIA PACIFIC: DIAGNOSTIC IMAGING SERVICES MARKET FOR ULTRASOUND APPLICATIONS, 2020-2027 (USD BILLION)
    • TABLE 109 ASIA PACIFIC: DIAGNOSTIC IMAGING SERVICES MARKET FOR NUCLEAR IMAGING APPLICATIONS, 2020-2027 (USD BILLION)
    • TABLE 110 ASIA PACIFIC: DIAGNOSTIC IMAGING SERVICES MARKET, BY END USER, 2020-2027 (USD BILLION)
    • 10.4.1 CHINA
      • 10.4.1.1 Expansion of diagnostic imaging facilities to support market growth
    • TABLE 111 CHINA: DIAGNOSTIC IMAGING SERVICES MARKET, BY MODALITY, 2020-2027 (USD BILLION)
    • 10.4.2 JAPAN
      • 10.4.2.1 Rapid adoption of advanced technologies and rising investments in diagnostic imaging procedures to support market growth
    • TABLE 112 JAPAN: DIAGNOSTIC IMAGING SERVICES MARKET, BY MODALITY, 2020-2027 (USD BILLION)
    • 10.4.3 INDIA
      • 10.4.3.1 Rising number of imaging centers and growing target patient pool to support market growth
    • TABLE 113 INDIA: DIAGNOSTIC IMAGING SERVICES MARKET, BY MODALITY, 2020-2027 (USD BILLION)
    • 10.4.4 SOUTH KOREA
      • 10.4.4.1 Rising focus on integration of AI in diagnostic imaging to support market growth
    • TABLE 114 SOUTH KOREA: DIAGNOSTIC IMAGING SERVICES MARKET, BY MODALITY, 2020-2027 (USD BILLION)
    • 10.4.5 AUSTRALIA
      • 10.4.5.1 Government funding to increase accessibility of diagnostic imaging services to drive market
    • TABLE 115 AUSTRALIA: DIAGNOSTIC IMAGING SERVICES MARKET, BY MODALITY, 2020-2027 (USD BILLION)
    • 10.4.6 REST OF ASIA PACIFIC (ROAPAC)
    • TABLE 116 REST OF ASIA PACIFIC: DIAGNOSTIC IMAGING SERVICES MARKET, BY MODALITY, 2020-2027 (USD BILLION)
  • 10.5 LATIN AMERICA
    • 10.5.1 RISING GERIATRIC POPULATION AND INCREASING DISEASE INCIDENCE TO SUPPORT MARKET GROWTH
    • TABLE 117 LATIN AMERICA: DIAGNOSTIC IMAGING SERVICES MARKET, BY MODALITY, 2020-2027 (USD BILLION)
    • TABLE 118 LATIN AMERICA: DIAGNOSTIC IMAGING SERVICES MARKET FOR X-RAY IMAGING APPLICATIONS, 2020-2027 (USD BILLION)
    • TABLE 119 LATIN AMERICA: DIAGNOSTIC IMAGING SERVICES MARKET FOR MAGNETIC RESONANCE IMAGING (MRI) APPLICATIONS, 2020-2027 (USD BILLION)
    • TABLE 120 LATIN AMERICA: DIAGNOSTIC IMAGING SERVICES MARKET FOR COMPUTED TOMOGRAPHY (CT) APPLICATIONS, 2020-2027 (USD BILLION)
    • TABLE 121 LATIN AMERICA: DIAGNOSTIC IMAGING SERVICES MARKET FOR ULTRASOUND APPLICATIONS, 2020-2027 (USD BILLION)
    • TABLE 122 LATIN AMERICA: DIAGNOSTIC IMAGING SERVICES MARKET FOR NUCLEAR IMAGING APPLICATIONS, 2020-2027 (USD BILLION)
    • TABLE 123 LATIN AMERICA: DIAGNOSTIC IMAGING SERVICES MARKET, BY END USER, 2020-2027 (USD BILLION)
  • 10.6 MIDDLE EAST & AFRICA
    • 10.6.1 IMPROVEMENTS IN HEALTHCARE SYSTEMS TO SUPPORT MARKET UPTAKE OF DIAGNOSTIC IMAGING SYSTEMS
    • TABLE 124 MIDDLE EAST & AFRICA: DIAGNOSTIC IMAGING SERVICES MARKET, BY MODALITY, 2020-2027 (USD BILLION)
    • TABLE 125 MIDDLE EAST & AFRICA: DIAGNOSTIC IMAGING SERVICES MARKET FOR X-RAY IMAGING APPLICATIONS, 2020-2027 (USD BILLION)
    • TABLE 126 MIDDLE EAST & AFRICA: DIAGNOSTIC IMAGING SERVICES MARKET FOR MAGNETIC RESONANCE IMAGING (MRI) APPLICATIONS, 2020-2027 (USD BILLION)
    • TABLE 127 MIDDLE EAST & AFRICA: DIAGNOSTIC IMAGING SERVICES MARKET FOR COMPUTED TOMOGRAPHY (CT) APPLICATIONS, 2020-2027 (USD BILLION)
    • TABLE 128 MIDDLE EAST & AFRICA: DIAGNOSTIC IMAGING SERVICES MARKET FOR ULTRASOUND APPLICATIONS, 2020-2027 (USD BILLION)
    • TABLE 129 MIDDLE EAST & AFRICA: DIAGNOSTIC IMAGING SERVICES MARKET FOR NUCLEAR IMAGING APPLICATIONS, 2020-2027 (USD BILLION)
    • TABLE 130 MIDDLE EAST & AFRICA: DIAGNOSTIC IMAGING SERVICES MARKET, BY END USER, 2020-2027 (USD BILLION)

11 COMPETITIVE LANDSCAPE

  • 11.1 OVERVIEW
  • 11.2 STRATEGIES ADOPTED BY KEY PLAYERS/RIGHT TO WIN
    • FIGURE 31 OVERVIEW OF STRATEGIES ADOPTED BY COMPANIES
  • 11.3 REVENUE ANALYSIS
    • FIGURE 32 REVENUE SHARE ANALYSIS OF TOP FIVE PLAYERS (2018-2021)
  • 11.4 DIAGNOSTIC IMAGING SERVICES MARKET: MARKET SHARE ANALYSIS, BY KEY PLAYER (2021)
    • FIGURE 33 MARKET SHARE ANALYSIS, 2021
    • TABLE 131 DIAGNOSTIC IMAGING SERVICES MARKET: DEGREE OF COMPETITION
  • 11.5 COMPANY EVALUATION QUADRANT FOR MAJOR PLAYERS (AS OF 2021)
    • 11.5.1 STARS
    • 11.5.2 EMERGING LEADERS
    • 11.5.3 PERVASIVE PLAYERS
    • 11.5.4 PARTICIPANTS
    • FIGURE 34 DIAGNOSTIC IMAGING SERVICES MARKET: COMPANY EVALUATION QUADRANT (2021)
  • 11.6 COMPANY EVALUATION QUADRANT (SMES/START-UPS)
    • 11.6.1 PROGRESSIVE COMPANIES
    • 11.6.2 RESPONSIVE COMPANIES
    • 11.6.3 DYNAMIC COMPANIES
    • 11.6.4 STARTING BLOCKS
    • FIGURE 35 DIAGNOSTIC IMAGING SERVICES MARKET: COMPETITIVE LEADERSHIP MAPPING (SMES/START-UPS)
  • 11.7 COMPETITIVE BENCHMARKING
    • TABLE 132 OVERALL FOOTPRINT ANALYSIS
    • TABLE 133 MODALITY FOOTPRINT ANALYSIS
    • TABLE 134 REGIONAL FOOTPRINT ANALYSIS
  • 11.8 COMPETITIVE SCENARIO (2019-2022)
    • 11.8.1 DEALS
    • 11.8.2 OTHER DEVELOPMENTS

12 COMPANY PROFILES

  • (Business Overview, Services Offered, Recent Developments, and MnM View (Key strengths/Right to Win, Strategic Choices Made, and Weaknesses and Competitive Threats))**
  • 12.1 RADNET, INC.
    • TABLE 135 RADNET, INC: BUSINESS OVERVIEW
    • FIGURE 36 RADNET, INC: COMPANY SNAPSHOT (2021)
    • TABLE 136 RADNET, INC: SERVICE OFFERINGS
  • 12.2 SONIC HEALTHCARE
    • TABLE 137 SONIC HEALTHCARE: BUSINESS OVERVIEW
    • FIGURE 37 SONIC HEALTHCARE: COMPANY SNAPSHOT (2021)
    • TABLE 138 SONIC HEALTHCARE: SERVICE OFFERINGS
  • 12.3 AKUMIN INC.
    • TABLE 139 AKUMIN INC. BUSINESS OVERVIEW
    • FIGURE 38 AKUMIN INC: COMPANY SNAPSHOT (2021)
    • TABLE 140 AKUMIN INC: SERVICE OFFERINGS
  • 12.4 HEALIUS LIMITED
    • TABLE 141 HEALIUS LIMITED: BUSINESS OVERVIEW
    • FIGURE 39 HEALIUS LIMITED: COMPANY SNAPSHOT (2021)
    • TABLE 142 HEALIUS LIMITED: SERVICE OFFERINGS
  • 12.5 DIGNITY HEALTH
    • TABLE 143 DIGNITY HEALTH: BUSINESS OVERVIEW
    • FIGURE 40 DIGNITY HEALTH: COMPANY SNAPSHOT (2021)
    • TABLE 144 DIGNITY HEALTHCARE: SERVICE OFFERINGS
  • 12.6 NOVANT HEALTH
    • TABLE 145 NOVANT HEALTH: BUSINESS OVERVIEW
    • FIGURE 41 NOVANT HEALTH: COMPANY SNAPSHOT (2021)
    • TABLE 146 NOVANT HEALTH: SERVICE OFFERINGS
  • 12.7 ALLIANCE MEDICAL
    • TABLE 147 ALLIANCE MEDICAL: BUSINESS OVERVIEW
    • TABLE 148 ALLIANCE MEDICAL: SERVICE OFFERINGS
  • 12.8 INHEALTH GROUP
    • TABLE 149 INHEALTH GROUP: BUSINESS OVERVIEW
    • TABLE 150 INHEALTH GROUP: SERVICE OFFERINGS
  • 12.9 APEX RADIOLOGY
    • TABLE 151 APEX RADIOLOGY: BUSINESS OVERVIEW
    • TABLE 152 APEX RADIOLOGY: SERVICE OFFERINGS
  • 12.10 CONCORD MEDICAL SERVICES HOLDINGS LIMITED
    • TABLE 153 CONCORD MEDICAL SERVICES HOLDINGS LIMITED: BUSINESS OVERVIEW
    • FIGURE 42 CONCORD MEDICAL SERVICES HOLDINGS LIMITED: COMPANY SNAPSHOT (2021)
    • TABLE 154 CONCORD MEDICAL SERVICES HOLDINGS LIMITED: SERVICE OFFERINGS
  • 12.11 RAYUS RADIOLOGY (CENTER FOR DIAGNOSTIC IMAGING, INC.)
    • TABLE 155 RAYUS RADIOLOGY: BUSINESS OVERVIEW
    • TABLE 156 RAYUS RADIOLOGY: SERVICE OFFERINGS
  • 12.12 UNILABS
    • TABLE 157 UNILABS: BUSINESS OVERVIEW
    • TABLE 158 UNILABS: SERVICE OFFERINGS
  • 12.13 AFFIDEA
    • TABLE 159 AFFIDEA: BUSINESS OVERVIEW
    • TABLE 160 AFFIDEA: SERVICE OFFERINGS
  • 12.14 I-MED RADIOLOGY NETWORK
    • TABLE 161 I-MED RADIOLOGY NETWORK: BUSINESS OVERVIEW
    • TABLE 162 I-MED RADIOLOGY NETWORK: SERVICE OFFERINGS
  • 12.15 CAPITOL IMAGING SERVICES
    • TABLE 163 CAPITOL IMAGING SERVICES: BUSINESS OVERVIEW
    • TABLE 164 CAPITOL IMAGING SERVICES: SERVICE OFFERINGS
  • 12.16 SIMONMED
    • TABLE 165 SIMONMED: BUSINESS OVERVIEW
    • TABLE 166 SIMONMED: SERVICE OFFERINGS
  • 12.17 CANADA DIAGNOSTIC CENTRES (CDC)
    • TABLE 167 CANADA DIAGNOSTIC CENTRES: BUSINESS OVERVIEW
    • TABLE 168 CANADA DIAGNOSTIC CENTRES: SERVICE OFFERINGS
  • 12.18 SHIELDS HEALTH CARE GROUP
    • TABLE 169 SHIELDS HEALTH CARE GROUP: BUSINESS OVERVIEW
    • TABLE 170 SHIELDS HEALTH CARE GROUP: SERVICE OFFERINGS
  • 12.19 ENVISION RADIOLOGY
    • TABLE 171 ENVISION RADIOLOGY: BUSINESS OVERVIEW
    • TABLE 172 ENVISION RADIOLOGY: SERVICE OFFERINGS
  • 12.20 PROGRESSIVE RADIOLOGY
    • TABLE 173 PROGRESSIVE RADIOLOGY: BUSINESS OVERVIEW
    • TABLE 174 PROGRESSIVE RADIOLOGY: SERVICE OFFERINGS
  • 12.21 OTHER PLAYERS
    • 12.21.1 QSCAN SERVICES PTY LTD
    • 12.21.2 PRP DIAGNOSTIC IMAGING
    • 12.21.3 INOVA
    • 12.21.4 ATLANTIC MEDICAL IMAGING
    • 12.21.5 ADVANCED DIAGNOSTICS HEALTHCARE SYSTEM, INC.
  • *Details on Business Overview, Services Offered, Recent Developments, and MnM View (Key strengths/Right to Win, Strategic Choices Made, and Weaknesses and Competitive Threats) might not be captured in case of unlisted companies.

13 APPENDIX

  • 13.1 DISCUSSION GUIDE
  • 13.2 KNOWLEDGESTORE: MARKETSANDMARKETS' SUBSCRIPTION PORTAL
  • 13.3 CUSTOMIZATION OPTIONS
  • 13.4 RELATED REPORTS
  • 13.5 AUTHOR DETAILS